Jana M Swenson

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 48:2469-75. 2010
  2. ncbi request reprint In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus
    Jana M Swenson
    Anti infectives Investigation Section, Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mailstop G08, 1600 Clifton Road N E, Atlanta, GA 30333, USA
    J Antimicrob Chemother 49:845-50. 2002
  3. pmc Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:1902-5. 2009
  4. pmc Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells
    Jana M Swenson
    Antimicrobial Resistance Team, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 45:3954-7. 2007
  5. ncbi request reprint Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs
    Jana M Swenson
    Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Diagn Microbiol Infect Dis 58:33-9. 2007
  6. pmc Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus
    Jana M Swenson
    Clinical and Environmental Microbiology Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:2013-7. 2009
  7. pmc Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mailstop G08, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 43:3818-23. 2005
  8. pmc Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods
    Jana M Swenson
    Division of Healthare Quality Promotion, Epidemiology and Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 42:5102-8. 2004
  9. pmc Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates
    Christine D Steward
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 41:351-8. 2003
  10. pmc Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp
    Ronald N Jones
    JMI Laboratories, North Liberty, IA 52317, USA
    J Clin Microbiol 45:227-30. 2007

Detail Information

Publications13

  1. pmc Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 48:2469-75. 2010
    ..Use of standardized MIC or disk tests could enable the detection of emerging high- and low-level mupirocin resistance in S. aureus...
  2. ncbi request reprint In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus
    Jana M Swenson
    Anti infectives Investigation Section, Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mailstop G08, 1600 Clifton Road N E, Atlanta, GA 30333, USA
    J Antimicrob Chemother 49:845-50. 2002
    ..faecium. The activity against four strains of glycopeptide-intermediate S. aureus was similar to that for other methicillin-resistant S. aureus isolates (range 0.5-2.0 mg/L)...
  3. pmc Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:1902-5. 2009
    ..For coagulase-negative strains at 24 h of incubation, breakpoints of < or = 2 microg/ml for mecA-negative and > or = 4 microg/ml for mecA-positive isolates gave sensitivity and specificity of 94 to 99% and 69 to 80%, respectively...
  4. pmc Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells
    Jana M Swenson
    Antimicrobial Resistance Team, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 45:3954-7. 2007
    ..After a 24-h incubation, the ERY-CC combinations of 4 and 0.5, 6 and 1, and 8 and 1.5 microg/ml correlated well with the D-zone test...
  5. ncbi request reprint Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs
    Jana M Swenson
    Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Diagn Microbiol Infect Dis 58:33-9. 2007
    ..These results suggest that a cefoxitin test can be used alone to predict mecA-mediated resistance in S. aureus...
  6. pmc Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus
    Jana M Swenson
    Clinical and Environmental Microbiology Branch, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 47:2013-7. 2009
    ..Only 12 (33.3%) strains for which the VA MICs were 4 microg/ml grew on VScr. The differentiation of isolates for which the VA MICs were 2 or 4 microg/ml was difficult for most systems and methods, including the reference methods...
  7. pmc Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp
    Jana M Swenson
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mailstop G08, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 43:3818-23. 2005
    ..These data were used to refine the description of the test in CLSI document M100-S15. The cefoxitin DD test is preferred over the oxacillin DD test for predicting mecA-mediated oxacillin resistance in S. aureus and CoNS...
  8. pmc Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods
    Jana M Swenson
    Division of Healthare Quality Promotion, Epidemiology and Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 42:5102-8. 2004
    ..Clinical laboratories should be aware of these discrepancies. At present, there are no data to indicate which method provides more clinically relevant information...
  9. pmc Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates
    Christine D Steward
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 41:351-8. 2003
    ....
  10. pmc Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp
    Ronald N Jones
    JMI Laboratories, North Liberty, IA 52317, USA
    J Clin Microbiol 45:227-30. 2007
    ..led to an unacceptable error rate (23.3%). However, an adjustment of tigecycline disk diffusion breakpoints (susceptible/resistant) to > or =16/ < or =12 mm reduced intermethod errors to an acceptable level (only 9.7%, all minor)...
  11. pmc Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods
    Ronald N Jones
    The JONES Group JMI Laboratories, Inc, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA
    J Clin Microbiol 43:925-7. 2005
    ..25 to 2 microg/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 mug/ml (14 to 18 mm). More than 97% of all reported QC results were within these proposed ranges...
  12. pmc Detection of staphylococci with reduced susceptibility to glycopeptides
    Mary Jane Ferraro
    J Clin Microbiol 40:1573. 2002
  13. pmc Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae
    Helio S Sader
    JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, Iowa 52317, USA
    J Clin Microbiol 45:1640-3. 2007
    ..Listed modifications were recently approved by the CLSI (M100-S17)...